Literature DB >> 28403581

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.

Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C Rowat, Sagar L Patil, Clara K Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A Moore, Jacquie E Schein, Andrew J Mungall, Jinsong Liu, Chad V Pecot, Anil K Sood, Steven J M Jones, Marco A Marra, Preethi H Gunaratne.   

Abstract

Entities:  

Year:  2017        PMID: 28403581      PMCID: PMC5370050          DOI: 10.18632/oncotarget.15921

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


× No keyword cloud information.
Present: ACKNOWLEDGMENTS The authors gratefully acknowledge the data production teams at the Genome Sciences Centre. Corrected: ACKNOWLEDGMENTS The authors gratefully acknowledge the data production teams at the Genome Sciences Centre. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov. Original article: Oncotarget. 2016; 7(18):25930–48. doi: 10.18632/oncotarget.8412.
  3 in total

1.  Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.

Authors:  Linjie Zhao; Wei Wang; Lian Xu; Tao Yi; Xia Zhao; Yuquan Wei; Louis Vermeulen; Ajay Goel; Shengtao Zhou; Xin Wang
Journal:  Oncogene       Date:  2018-11-26       Impact factor: 9.867

2.  Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma.

Authors:  Santosh K Singh; Manoj K Mishra; Brian M Rivers; Jennifer B Gordetsky; Sejong Bae; Rajesh Singh
Journal:  Cancers (Basel)       Date:  2020-04-05       Impact factor: 6.639

3.  MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Huiming Zhang; Shuang Liu; Liqiang Chen; Yanliang Sheng; Wenzhe Luo; Gang Zhao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.